InvestorsHub Logo
Followers 87
Posts 32825
Boards Moderated 1
Alias Born 12/19/2004

Re: None

Monday, 11/08/2021 9:46:38 AM

Monday, November 08, 2021 9:46:38 AM

Post# of 30352
Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar Ataxia

https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/86490794/seelos-therapeutics-announces-fda-acceptance-of-in
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News